Biden di­rec­tive on screen­ing for­eign in­vest­ments in US biotech not tar­get­ed at Chi­na, ad­min of­fi­cials say

3 years ago
China
Law

That $930M drug Alex­ion bought to pair with Soliris, Ul­tomiris? As­traZeneca says it just aced a PhI­II test

3 years ago
R&D

Scor­pi­on snags a Sanofi vet to lead the way to the clin­ic; All eyes on eli-cel as blue­bird seeks a fi­nance leader — ...

3 years ago
Peer Review

Lancet com­mis­sion sharply cri­tiques WHO and gov­ern­ments over their Covid re­sponse

3 years ago
Coronavirus

Gilead aims to dri­ve health eq­ui­ty through ed­u­ca­tion eq­ui­ty with new $20M fund

3 years ago
Pharma
Marketing

Van­da sues FDA yet again, ac­cus­es fed­er­al agency of de­lay­ing post-CRL hear­ing

3 years ago
FDA+
Law

Illi­nois phar­ma com­pa­ny to pay al­most $8M af­ter sell­ing OTC drugs un­der ob­so­lete pre­scrip­tion-on­ly la­bels

3 years ago
Pharma
Law

Sen­a­tors ques­tion how HHS plans to roll out new drug pric­ing re­forms

3 years ago
Pharma
Law

No­var­tis files an­oth­er FDA pe­ti­tion to halt En­tresto com­pe­ti­tion as block­buster fight ap­proach­es

3 years ago
FDA+

Man­u­fac­tur­ing roundup: WuXi STA un­veils new fa­cil­i­ty; Pur­due Uni­ver­si­ty nets $3M grant for ze­ro-waste phar­ma ...

3 years ago
Manufacturing

As­traZeneca and peo­ple who are im­muno­com­pro­mised, in­clud­ing celebs, re­mind us they're 'still here’ in new Covid ...

3 years ago
Pharma
Marketing

Fu­ji­film Diosynth breaks ground on a $1.6B ex­pan­sion project in Den­mark

3 years ago
Cell/Gene Tx
Manufacturing

NIH pumps $130M in­to health and med­i­cine AI re­search

3 years ago
R&D

Trou­bled times: With its back against the wall, lit­tle Tenax sends out an SOS while IMV takes out the bud­get axe, ...

3 years ago
People
Pharma

Mallinck­rodt se­cures FDA ap­proval — but not with­out warn­ing; Rhythm seeks $100M af­ter reg­u­la­to­ry OKs

3 years ago
News Briefing

Eloxx re­ports PhII cys­tic fi­bro­sis fail as the biotech weighs its op­tions

3 years ago
R&D

MD An­der­son wants to 'be part of the game,' part­ners with Ra­dio­pharm Ther­a­nos­tics for ra­di­oli­gand joint ven­ture

3 years ago
Startups
Deals

FDA un­veils list of al­ter­na­tive ways to com­ply with cGMP re­quire­ments for com­bo prod­ucts

3 years ago
Pharma
FDA+

Up­dat­ed: Striv­ing for 2023 launch, Pfiz­er touts topline PhI­II win for an­oth­er mass mar­ket vac­cine

3 years ago
R&D

The virus shred­der: A Prince­ton spin­out ad­vised by a high-pro­file VC launch­es a Cas13 vi­ral de­fense sys­tem

3 years ago
Financing

'Pluck­ing our way up that list': Bay­er high­lights on­col­o­gy am­bi­tions in new Kendall Square labs

3 years ago
R&D
Pharma

From three com­pa­nies to one — Gal­va­nize Ther­a­peu­tics gets $100M to push elec­tric field ther­a­py

3 years ago
Financing
Startups

First of more? Third Har­mon­ic prices up­sized IPO to raise $185M

3 years ago
Financing

Swiss reg­u­la­tors in­ves­ti­gate No­var­tis over 'un­law­ful abuse' of der­ma­tol­ogy patent

3 years ago
Pharma
Law
First page Previous page 461462463464465466467 Next page Last page
A service from the Financial Times